Lewy pathology and neurodegeneration in premotor Parkinson's disease.
about
Ageing and Parkinson's disease: why is advancing age the biggest risk factor?Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Spreading of pathology in neurodegenerative diseases: a focus on human studiesParkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and DiagnosisPREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline resultsHippocampal α-synuclein and interneurons in Parkinson's disease: Data from human and mouse models.Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans.Cutaneous neuropathy in Parkinson's disease: a window into brain pathology.Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.Premotor and nonmotor features of Parkinson's disease.Dysautonomia in Parkinson diseaseA vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease.Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice.CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease.Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.Idiopathic REM sleep behaviour disorder in the development of Parkinson's diseasePathophysiology of Small-Fiber Sensory System in Parkinson's Disease: Skin Innervation and Contact Heat Evoked Potential.Parkinsonian Balance Deficits Quantified Using a Game Industry Board and a Specific Battery of Four Paradigms.Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff.Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease.The significance of defining preclinical or prodromal Parkinson's disease.Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia.The pathology roadmap in Parkinson disease.Is there a need to redefine Parkinson's disease?α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.The pathomechanisms underlying Parkinson's disease.The prion hypothesis of Parkinson's disease.The relevance of pre-motor symptoms in Parkinson's disease.The Concept of Prodromal Parkinson's Disease.Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.Sleep disorders and an increased risk of Parkinson's disease in individuals with non-apnea sleep disorders: a population-based cohort study.The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states.Locus coeruleus.Involvement of catecholaminergic neurons in motor innervation of striated muscle in the mouse esophagus.Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate.Somatosensory symptoms in unmedicated de novo patients with idiopathic Parkinson's disease.Association between two α-2-macroglobulin gene polymorphisms and Parkinson's disease: a meta-analysis.Proceedings: cell therapies for Parkinson's disease from discovery to clinic.
P2860
Q27021628-2B38F329-7FCD-4526-B6CA-9201B11D7292Q27322513-DC4B87E5-0F9B-4D79-99A3-3317F8095CD0Q28082279-E3578816-8E35-4F73-A3BD-A0E454DD8CFAQ28384572-363758BA-8621-4574-AB6C-32D4C143AC18Q30564071-9D648997-0966-46A4-9A6A-C19E14AD2015Q31060511-325DD189-8068-4271-BF4A-D9F125D46F84Q33729960-CD3585F4-D51E-4E5D-9435-211D3FD73633Q33764504-B1D726B1-2EC2-438D-9066-116DF29DF205Q34159183-D872C828-7B03-494C-8741-9B7269A1EEE5Q34274224-202795E6-9023-44D6-8465-1B333ABFCB3CQ34463831-1BE2A255-E209-419D-9C89-F586DE4CD78BQ34560077-3A02903B-F2E3-4246-8671-EAE84849E278Q35000199-8DCBF729-8B2D-4FFA-A35B-97E6993D01DEQ36275740-633127AD-A82B-412A-B5F9-51B571B58BB9Q36351543-378500D8-E053-472F-B08A-0D6D26D56AA6Q36656691-43C9606E-9446-43FF-BA7D-2600919DF479Q37207179-148914A4-68EE-423C-A383-719EC4BDE3F5Q37214996-C537B095-4B22-4F7D-A90F-59A155CEC96EQ37693339-019776FB-40AF-4DF3-A85E-74A654BC8C50Q37727060-0321A544-0EDB-44D9-8F9C-251CA0F3ABDDQ38003068-06E5CA94-965D-4944-A6F0-8DB9FCFCD444Q38051969-6652F841-D492-4601-B51A-6C71B4F701DCQ38074519-F9448535-76DD-4A89-8407-DFAFFABB273BQ38110209-DAC0B6AD-CB49-4FCD-9AE6-F7DCB95F2D77Q38153587-9CC1B96F-B738-47FB-A28D-7560C7F835FAQ38182660-1DF5463B-E638-4B12-8265-3BDDE95EE432Q38418624-DD0BE764-619F-491E-9C53-A929FDC10A3AQ38594857-C7B26E3C-2BD5-4F28-8829-03D53245D640Q38612230-00D261FD-1AEA-44AE-9629-632F09D2A883Q38667942-68101F97-C78E-435D-AC9C-E790DE1AE56DQ38687864-B2BB1A26-21A7-4550-840F-EC83A41863F0Q39052041-EFC23F09-23E2-4CAD-B7E1-A9F9ED4B91F8Q39125374-5A079D2A-D36C-45F6-B049-6E6B906D964FQ39422119-5CB94BE6-DC19-4EC1-968B-9C2B32A60E1BQ40078793-671A11F5-D231-41C9-8384-4D6652DC0454Q40280525-59D46A54-F30A-4F04-A3CA-82DA7D5E2624Q40790760-C28B88DB-B955-46D3-AFF3-034DD5AE183FQ41336889-02D23272-D4E1-49FC-A6F4-80A4B73A9245Q41703924-8E35B9DC-6B05-41EA-AA66-00DCB73FC91FQ42545361-B73648F1-B971-4A21-B33E-147181A20D0B
P2860
Lewy pathology and neurodegeneration in premotor Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lewy pathology and neurodegeneration in premotor Parkinson's disease.
@en
type
label
Lewy pathology and neurodegeneration in premotor Parkinson's disease.
@en
prefLabel
Lewy pathology and neurodegeneration in premotor Parkinson's disease.
@en
P2860
P356
P1433
P1476
Lewy pathology and neurodegeneration in premotor Parkinson's disease.
@en
P2093
Heiko Braak
Kelly Del Tredici
P2860
P304
P356
10.1002/MDS.24921
P407
P577
2012-04-01T00:00:00Z